Sunday, October 25, 2026

WD 361: Brazil, JetBlue Bankruptcy, Mexican Airlines Merger

Brazil’s Lula victory leaves Nu and Inter’s thesis intact, while JetBlue heads toward bankruptcy and Mexican airlines pursue a merger.

NU $56B

Ian’s Insider Corner Oct 25 11 clicks

Oct 25 AXP $217B

American Express: P&L Slowed, Consumer Didn’t

Librarian Capital's Research Library 4 clicks

Oct 25 PM $325B

Philip Morris International: Ho-hum Hrmm?

Invariant 13 clicks

From X

@Adam_Wyden Mar 26

Adam D. Wyden on X

$DRVN

@gatorcapital Mar 17

Derek Pilecki on X

@DavidBrail Doesn’t seem like they will. But, for the new bid to be worse than Trian’s $49/share cash bid, committee would have to assume $VCTR shares decline 45% to $36. That seems like an unreasonable assumption because Victory would then trade at a 3x P/E.

@gatorcapital Mar 17

Derek Pilecki on X

New $VCTR bid for $JHG. In the slide deck, Victory says the deal will result in +50% accretion. 2027 EPS goes from $7.56 to at least $11.34. The combined company would trade at 6x 2027 EPS.

@HedgeyeRetail Mar 10

Brian McGough on X

Hey $KSS...Thanks for showing up today. You 'beat the quarter'. Golf clap. Comp missed. GM missed. Made the FCF number by cutting SG&A and Capex. Basically burning the office furniture. Extended payables -- vendors working with you to stay alive -- until the don't. $NKE will be the first to pull. Then you file...

@CapitalVoss Mar 4

Voss Capital on X

The Voss Q4 2025 Letter to Partners is up. Updates on $PAR, $FLYW, $CLBT, and new core idea $CHH, an asset light hotel franchisor that has rarely ever been cheaper. https://t.co/DTOoXGIN0M https://t.co/gjWBSHET4j

@CapitalVoss Mar 4

Voss Capital on X

Voss Capital Issues Open Letter to the Board of Euronet Worldwide $EEFT https://t.co/ZpE7cH201Q

@MultiplesCap Mar 4

Multiples Capital on X

I recently sat down with @StockJabber at @IdeaBrunchEmail to discuss the strategy behind Multiples Capital's outperformance in 2025. The full interview is behind a paywall, but here are 4 core themes we discussed: 1/ The Multi-Asset Edge While many leaned on the "Magnificent 7," we found alpha in global de-dollarization and the massive electricity demands of AI data centers. This approach delivered a 3.15 Sharpe Ratio—with roughly half the turbulence of the S&P 500. 2/ Garrett Motion ($GTX) Update Since my last feature, $GTX has surged ~170%. We discussed the "perfect storm" of index inclusion and aggressive capital allocation that drove this run, and why the "EV-only" fear proved to be premature. 3/ AI Disruption vs. Mispricing The market is correctly identifying "AI Losers" in SaaS, but it’s applying that same anxiety with broad stroke. We broke down why Expedia ($EXPE) is a prime example of this mispricing, trading at a 12%+ FCF yield despite its essential role in the global travel ecosystem and it's growing B2B setment. 4/ My Favorite "Tokenization" Play We closed with a deep dive into the digitalization of finance. I shared my top idea for playing the tokenization trend, a company currently acting as the "digital infrastructure provider" for institutions and growing it's subscription and service revenues. Read the full deep dive here: https://t.co/kuRyJtSPMh Note: As this is premium content, I cannot share the PDF on a open platform. However, if you’d like to join my quarterly investor letter distribution list to see how we are positioning for the "Broadening Trade" in 2026, please send a DM.

@1MainCapital Mar 4

Yaron Naymark on X

Insider buys usually feel like PR fluff. But $45M into $KKR at these levels is clearly an investment, not signaling. Especially meaningful coming from guys whose entire schtick is figuring out what things are worth... https://t.co/w5KSbF0VMj

Signet Jewelers (SIG): The Next Dillard’s?

Signet Jewelers cut its share count from 87 million to 38 million since 2012 as short interest reaches 15%, amid a hated diamond market.

SIG $4.5B

Cannibal Stocks Oct 25 20 clicks

Tower Semiconductor Deep Dive

Tower Semiconductor’s low-loss photonics chips halve lasers in 1.6T optical modules, supporting a $680 million annualized photonics run…

TSEM $18B

CV's Substack Oct 24 10 clicks

Expert Call | AI Server OEM: 2026 xAI Orders, GB300 Price Hikes & B300 Margin Gains

Super Micro’s 2026 xAI rack orders, GB300 price increases and B300 mix frame its gross-margin outlook.

SMCI $22B

P Equity Research Oct 24 8 clicks

I went through all 142 companies in Value Line this morning. Here are the 6 that made it

Six Value Line small caps including Blackbaud, Marqeta, Ranger Energy and Definitive Healthcare trade on net cash, buybacks, low multiples…

BLKB $2.4B

Calvin Blissett Oct 24 81 clicks

Ares Capital: This 10%+ Yield Is An Undervalued Buy

Ares Capital’s 10%+ yield is supported by a $30.5 billion portfolio with over 70% floating-rate debt, though dividend coverage remains…

ARCC $14B

Jonathan Weber Oct 24 6 clicks

Margin Call

Petrobras’s Morpho-1 well revived hopes that Brazil’s Equatorial Margin can become a major new oil frontier after hydrocarbons were…

PBR $81B

Doomberg Oct 24 13 clicks

Applied Materials: Buy The Engineering Powerhouse Behind AI

Applied Materials targets AI-driven demand for advanced logic, DRAM and packaging, supported by services revenue and operating leverage…

AMAT $310B

Dhierin Bechai Oct 24 5 clicks

AI Narrative Switched, Debt Yields Spike | The Weekly Wrap

CoreWeave’s rising debt yields and fading confidence in AI data-center economics frame a weekly review of Meta, Tesla, SpaceX, Netflix,…

CRWV $34B

Steve Eisman Oct 23 29 clicks

Our Views on CoreWeave

CoreWeave's financial statements point to a business model familiar to the authors after a closer review of the AI infrastructure company.

CRWV $34B

WHAT ARE WE DOING? “Contrarians At The Gate” Oct 23 13 clicks

DigitalOcean's AI Flywheel: Unleashing Massive Growth Potential For Bold Investors

DigitalOcean is pivoting toward affordable AI infrastructure and inference workloads, targeting share from AWS and Google Cloud amid…

DOCN $12B

Star Investments Oct 23 9 clicks

JBFCY · long

Jollibee Foods CORP

Jollibee Foods trades at PHP 144, about 56% below its January 2019 high, framing a long thesis on the Philippine restaurant operator.

JBFCY $2.6B

Value Investors Club Jul 27 1 click

SLB Stock: Upgrading Back To A Buy As The Earnings Recovery Takes Shape

SLB’s Q3 beats, sequential margin gains and roughly $10 billion Q4 revenue guide support an earnings recovery despite flat Middle East…

SLB $78B

Steven Fiorillo Oct 24 3 clicks

Bloom Energy (NYSE: BE) Q3 FY12/26 Earnings - Revenue Up 138% On The Datacenter Power Race

Bloom Energy’s Q3 FY26 revenue rose 138% to $1.24 billion as datacenter power orders lifted operating margin to 18%; capex drove $181…

BE $63B

Cestrian Capital Research Oct 23 10 clicks

Philip Morris: Taking the Fight to the U.S.

Philip Morris reported Q3 growth across heated tobacco, combustibles and e-vapor in Europe while gaining U.S. nicotine-pouch share.

PM $325B

Librarian Capital's Research Library Oct 23 5 clicks

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $34B

Net Interest Oct 23 12 clicks

Spotify 3Q’26: Built for the Background

Spotify's third-quarter results met or exceeded guidance, with 306 million Premium subscribers and €672 million operating income, while…

SPOT $122B

MBI Deep Dives Oct 23 4 clicks

TSOH Weekly Roundup (10/23/2026)

TSOH Weekly Roundup covers Ally’s improving credit and capital returns, Pepsi’s weak beverage brands, and Match Group’s plan to revive…

ALLY $12BMTCH $9.7B

TSOH Investment Research Oct 23 5 clicks

Texas Instruments (NASDAQ: TXN) Stock Rating: HOLD After Q3 FY12/26 Earnings

Texas Instruments reported Q3 revenue of $6.06 billion, up 28%, with 47% operating margin and Q4 guidance above seasonal norms; Cestrian…

TXN $285B

Cestrian Capital Research Oct 23 7 clicks

Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch

Tempus AI targets $1.6 billion of 2026 revenue through AI diagnostics, data licensing and cancer-testing partnerships, with Personalis…

TEM $13BMRNA $89B

Edmund Ingham Oct 23 7 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B

Best Anchor Stocks Oct 23 15 clicks

Sunday, October 25, 2026

Adam D. Wyden on X

Derek Pilecki on X

Derek Pilecki on X

Brian McGough on X

Voss Capital on X

Voss Capital on X

Multiples Capital on X

Yaron Naymark on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 69 of 271

X accounts we follow

Investor letters we follow

Sectors